| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AIMMUNE THERAPEUTICS INC COM | 3,992,517 | 86,757,000 | 37.22% | ||
| 2 | AERIE PHARMACEUTICALS INC COM | 1,573,026 | 71,337,000 | 30.60% | ||
| 3 | EPIZYME INC COM | 1,543,118 | 26,464,000 | 11.35% | ||
| 4 | ALDER BIOPHARMACEUTICALS INC | 956,041 | 19,886,000 | 8.53% | ||
| 5 | NANOSTRING TECHNOLOGIES INC | 492,539 | 9,787,000 | 4.20% | ||
| 6 | DERMIRA INC COM | 185,294 | 6,320,000 | 2.71% | ||
| 7 | NEXVET BIOPHARMA PUB LTD CO | 877,134 | 3,412,000 | 1.46% | ||
| 8 | JOUNCE THERAPEUTICS INC | 119,912 | 2,637,000 | 1.13% | ||
| 9 | OREXIGEN THERAPEUTICS INC | 622,013 | 2,140,000 | 0.92% | ||
| 10 | ZAFGEN INC COM | 449,464 | 2,095,000 | 0.90% | ||
| 11 | BELLICUM PHARMACEUTICALS INCORPORATED | 105,000 | 1,296,000 | 0.56% | ||
| 12 | ACCELERON PHARMA INC | 19,910 | 527,000 | 0.23% | ||
| 13 | Natera, Inc. | 50,737 | 450,000 | 0.19% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-026668, filed 2017.05.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
